Alexion Gains First Potential Drug for Hypophosphatasia via US$1.08 B Enobia Buyout
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 6 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1674 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Alexion Pharmaceuticals has agreed to acquire Enobia Pharma for up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS